| Poly(ethyl ethylene phosphate): overcoming the "Polyethylene Glycol Dilemma" for cancer immunotherapy and mRNA vaccination
Yu, X., Li, H., Dong, C., Qi, S., Yang, K., Bai, B., … Yu, G. (2023). Poly(ethyl ethylene phosphate): overcoming the "Polyethylene Glycol Dilemma" for cancer immunotherapy and mRNA vaccination. ACS Nano, 17(23), 23814-23828. https://doi.org/10.1021/acsnano.3c07932 |
| Tailoring design of nanomaterials and systems to individualize patient treatments
Buljan, M., & Wick, P. (2022). Tailoring design of nanomaterials and systems to individualize patient treatments. Chimia, 76(3), 236-241. https://doi.org/10.2533/chimia.2022.236 |
| Future perspectives for advancing regulatory science of nanotechnology-enabled health products
Halamoda-Kenzaoui, B., Geertsma, R., Pouw, J., Prina-Mello, A., Carrer, M., Roesslein, M., … Bremer-Hoffmann, S. (2022). Future perspectives for advancing regulatory science of nanotechnology-enabled health products. Drug Delivery and Translational Research, 12, 2145-2156. https://doi.org/10.1007/s13346-022-01165-y |
| Research on nanoparticles in human perfused placenta: state of the art and perspectives
Aengenheister, L., Favaro, R. R., Morales-Prieto, D. M., Furer, L. A., Gruber, M., Wadsack, C., … Buerki-Thurnherr, T. (2021). Research on nanoparticles in human perfused placenta: state of the art and perspectives. Placenta, 104, 199-207. https://doi.org/10.1016/j.placenta.2020.12.014 |
| Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Character
Caputo, F., Mehn, D., Clogston, J. D., Rösslein, M., Prina-Mello, A., Borgos, S. E., … Calzolai, L. (2021). Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory. Journal of Chromatography A, 1635, 461767 (12 pp.). https://doi.org/10.1016/j.chroma.2020.461767 |
| Precision in thermal therapy: clinical requirements and solutions from nanotechnology
Gschwend, P. M., Hintze, J. M., Herrmann, I. K., Pratsinis, S. E., & Starsich, F. H. L. (2021). Precision in thermal therapy: clinical requirements and solutions from nanotechnology. Advanced Therapeutics, 4(2), 2000193 (13 pp.). https://doi.org/10.1002/adtp.202000193 |
| Uniting drug and delivery: metal oxide hybrid nanotherapeutics for skin wound care
Matter, M. T., Probst, S., Läuchli, S., & Herrmann, I. K. (2020). Uniting drug and delivery: metal oxide hybrid nanotherapeutics for skin wound care. Pharmaceuticals, 12(8), 780 (17 pp.). https://doi.org/10.3390/pharmaceutics12080780 |
| Emerging standards and analytical science for nanoenabled medical products
Nelson, B. C., Minelli, C., Doak, S. H., & Roesslein, M. (2020). Emerging standards and analytical science for nanoenabled medical products. Annual Review of Analytical Chemistry, 13(1), 431-452. https://doi.org/10.1146/annurev-anchem-091619-102216 |
| Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: from production to clinical practice
Nikravesh, N., Borchard, G., Hofmann, H., Philipp, E., Flühmann, B., & Wick, P. (2020). Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: from production to clinical practice. Nanomedicine: Nanotechnology, Biology and Medicine, 26, 102178 (11 pp.). https://doi.org/10.1016/j.nano.2020.102178 |
| Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity
Caputo, F., Clogston, J., Calzolai, L., Rösslein, M., & Prina-Mello, A. (2019). Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity. Journal of Controlled Release, 299, 31-43. https://doi.org/10.1016/j.jconrel.2019.02.030 |
| Supramolecular insights into domino effects of Ag@ZnO-induced oxidative stress in melanoma cancer cells
Ghaemi, B., Moshiri, A., Herrmann, I. K., Hajipour, M. J., Wick, P., Amani, A., & Kharrazi, S. (2019). Supramolecular insights into domino effects of Ag@ZnO-induced oxidative stress in melanoma cancer cells. ACS Applied Materials and Interfaces, 11(15), 46408-46418. https://doi.org/10.1021/acsami.9b13420 |
| Bridging communities in the field of nanomedicine
Halamoda-Kenzaoui, B., Baconnier, S., Bastogne, T., Bazile, D., Boisseau, P., Borchard, G., … Bremer-Hoffmann, S. (2019). Bridging communities in the field of nanomedicine. Regulatory Toxicology and Pharmacology, 106, 187-196. https://doi.org/10.1016/j.yrtph.2019.04.011 |
| Engineered nanomaterials and human health: Part 2. Applications and nanotoxicology (IUPAC Technical Report)
Gubala, V., Johnston, L. J., Krug, H., Moore, C. J., Ober, C. K., Schwenk, M., & Vert, M. (2018). Engineered nanomaterials and human health: Part 2. Applications and nanotoxicology (IUPAC Technical Report). Pure and Applied Chemistry, 90(8), 1325-1356. https://doi.org/10.1515/pac-2017-0102 |
| Preclinical hazard evaluation strategy for nanomedicines
Siegrist, S., Cörek, E., Detampel, P., Sandström, J., Wick, P., & Huwyler, J. (2018). Preclinical hazard evaluation strategy for nanomedicines. Nanotoxicology, 13(1), 73-99. https://doi.org/10.1080/17435390.2018.1505000 |
| Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines
Rösslein, M., Liptrott, N. J., Owen, A., Boisseau, P., Wick, P., & Herrmann, I. K. (2017). Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines. Nanotoxicology, 11(2), 147-149. https://doi.org/10.1080/17435390.2017.1279361 |
| Personalized medicine: the enabling role of nanotechnology
Herrmann, I. K., & Rösslein, M. (2016). Personalized medicine: the enabling role of nanotechnology. Nanomedicine, 11(1), 1-3. https://doi.org/10.2217/nnm.15.152 |
| Determination of the transport rate of xenobiotics and nanomaterials across the placenta using the <I>ex vivo</I> human placental perfusion model
Grafmüller, S., Manser, P., Krug, H. F., Wick, P., & von Mandach, U. (2013). Determination of the transport rate of xenobiotics and nanomaterials across the placenta using the ex vivo human placental perfusion model. Journal of Visualized Experiments (76), e50401 (7 pp.). https://doi.org/10.3791/50401 |